Regulatory effects of miR-30c knockout on hepatic lipid metabolism and progression of liver fibrosis
BMC Gastroenterology · 2025
DOI: 10.1186/s12876-025-04237-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Gastroenterology, 2025. Verfasst von Shasha Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, the First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Lipid Metabolism, MicroRNAs, Liver Cirrhosis, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National College Students' Innovative Entrepreneurial Training Plan Program, Provincial College Students' Innovative Entrepreneurial Training Plan Program of Anhui, Science Research Project of Bengbu Medical University.
Abstract (Originalsprache)
BACKGROUND: Liver fibrosis is a chronic progressive liver disease influenced by environmental and genetic factors. Early stages of liver fibrosis are marked by abnormal fat deposition in the liver. MicroRNA-30c (miR-30c) plays key roles in various pathological processes, including lipid metabolism, metabolic disorders, and cancer. However, the precise role of miR-30c in the progression of liver fibrosis remains unclear. This study aimed to investigate the role of miR-30c in liver fibrosis using miR-30c knockout (KO) mice. METHODS: KO mice were compared to wild-type (WT) mice to evaluate growth and development, with a focus on lipid metabolism markers. Liver transcriptomic analysis was performed to explore gene expression alterations due to miR-30c knockout. To induce liver fibrosis, thioacetamide (TAA) was administered to the mice, allowing the assessment of the impact of miR-30c on fibrosis initiation and progression. RESULTS: The results showed that miR-30c knockout led to body weight loss and disrupted lipid metabolism in mice. A total of 212 upregulated genes and 267 downregulated genes were identified in the livers of KO mice by RNA-seq. Differential enrichment of lipid metabolism pathways was observed KO mice, including PPAR signaling pathway, fatty acid degradation, biosynthesis of unsaturated fatty acids, and so on. The deletion of miR-30c aggravated the liver injury induced by TAA and increased the structural disorder of hepatocytes, and miR-30c knockout mice showed more severe liver fibrosis. This study establishes miR-30c as protective against liver fibrosis progression. CONCLUSION: The deficiency of miR-30c might exacerbate fibrosis and inflammation, while also disrupting lipid metabolism, suggesting that miR-30c modulation shows therapeutic potential based on mechanistic evidence. Further exploration of miR-30c-mediated crosstalk between metabolic and inflammatory pathways could advance therapeutic strategies for fibrotic liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, the First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University, Bengbu, China.
- School of Basic Courses, Bengbu Medical University, Bengbu, China.
- Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, Bengbu Medical University, Bengbu Medical University, Bengbu, China.
- School of Life Science, Bengbu Medical University, Bengbu, China.
- School of Clinical Medicine, Bengbu Medical University, Bengbu, China.
- School of Life Science, Bengbu Medical University, Bengbu, China. gaoyu@bbmu.edu.cn.
Förderung
- National College Students' Innovative Entrepreneurial Training Plan Program
- Provincial College Students' Innovative Entrepreneurial Training Plan Program of Anhui
- Science Research Project of Bengbu Medical University
- Natural Science Research Project of Anhui Educational Committee
- National College Students’ Innovative Entrepreneurial Training Plan Program
- Provincial College Students’ Innovative Entrepreneurial Training Plan Program of Anhui
Zitieren
APA
Ma, S., Yang, M., Qiang, W., Zhou, F., Chen, Z., Gao, Y., & Zhang, L. (2025). Regulatory effects of miR-30c knockout on hepatic lipid metabolism and progression of liver fibrosis. BMC Gastroenterology. https://doi.org/10.1186/s12876-025-04237-8
Vancouver
Ma S, Yang M, Qiang W, Zhou F, Chen Z, Gao Y, et al. Regulatory effects of miR-30c knockout on hepatic lipid metabolism and progression of liver fibrosis. BMC Gastroenterology. 2025. doi:10.1186/s12876-025-04237-8
BibTeX
@article{Ma2025,
author = {Ma, Shasha and Yang, Minghui and Qiang, Weiye and Zhou, Feng and Chen, Zuo and Gao, Yu and Zhang, Li},
title = {Regulatory effects of miR-30c knockout on hepatic lipid metabolism and progression of liver fibrosis},
journal = {BMC Gastroenterology},
year = {2025},
doi = {10.1186/s12876-025-04237-8}
}
EUVIMED